Industry Research Reports
Home > Reports > Chemical & Material > Global Gamma Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Gamma Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Gamma Valerolactone Market Size(US$)
CAGR 2025-2031
1.3%
Market Size,2031
USD 651
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 602 million
Market Forecast in 2031(Value)
US$ 651 million
CAGR
1.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on. In 2024, global Gamma Valerolactone production reached approximately 26552 MT, with an average global market price of around US$ 19 per kg.
Gamma-valerolactone (GVL) is a renewable organic compound derived mainly from biomass sources such as lignocellulosic materials. It serves as a versatile green solvent, fuel additive, and intermediate in the production of chemicals, polymers, and pharmaceuticals. Its environmentally friendly profile, biodegradability, and relatively low toxicity make it attractive in applications where sustainable alternatives are sought to replace petroleum-based solvents and intermediates. GVL is also being explored as a platform molecule for producing biofuels and value-added chemicals, further enhancing its strategic importance in the shift toward a circular and bio-based economy.
The market for gamma-valerolactone is driven by the growing demand for green solvents in industrial processes, the need for sustainable fuel additives, and the rising interest in bio-based chemicals. Key end-use industries include chemicals, energy, pharmaceuticals, and agrochemicals, with research and development playing a significant role in expanding its commercial viability. However, challenges such as high production costs and limited large-scale manufacturing capacity currently restrict its widespread adoption. As advances in biomass conversion technologies mature and scale up, the market is expected to expand steadily, with strong opportunities in regions focusing on renewable energy and sustainable chemical production.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gamma Valerolactone market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Anhui Hyea Aromas
- Dideu Industries
- Kunshan Qiandeng Baihua
- Zhongyue Aroma
- Soda Aromatic
- Inoue Perfumery MFG
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Food Grade
- Industrial Grade
Segment by Application
- Food Flavors
- Solvent
- Monomer Intermediate
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Gamma Valerolactone study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report?
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Gamma Valerolactone: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gamma Valerolactone Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Food Grade
1.2.3 Industrial Grade
1.3 Market Segmentation by Application
1.3.1 Global Gamma Valerolactone Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food Flavors
1.3.3 Solvent
1.3.4 Monomer Intermediate
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gamma Valerolactone Revenue Estimates and Forecasts 2020-2031
2.2 Global Gamma Valerolactone Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Gamma Valerolactone Sales Estimates and Forecasts 2020-2031
2.4 Global Gamma Valerolactone Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Gamma Valerolactone Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Gamma Valerolactone Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Gamma Valerolactone Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Food Grade Market Size by Manufacturers
4.5.2 Industrial Grade Market Size by Manufacturers
4.6 Global Gamma Valerolactone Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Gamma Valerolactone Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Gamma Valerolactone Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Gamma Valerolactone Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Gamma Valerolactone Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Gamma Valerolactone Sales and Revenue by Type (2020-2031)
7.4 North America Gamma Valerolactone Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Gamma Valerolactone Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Gamma Valerolactone Sales and Revenue by Type (2020-2031)
8.4 Europe Gamma Valerolactone Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Gamma Valerolactone Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Gamma Valerolactone Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Gamma Valerolactone Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Gamma Valerolactone Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Gamma Valerolactone Sales and Revenue by Type (2020-2031)
10.4 Central and South America Gamma Valerolactone Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Gamma Valerolactone Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Gamma Valerolactone Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Gamma Valerolactone Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Gamma Valerolactone Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Anhui Hyea Aromas
12.1.1 Anhui Hyea Aromas Corporation Information
12.1.2 Anhui Hyea Aromas Business Overview
12.1.3 Anhui Hyea Aromas Gamma Valerolactone Product Models, Descriptions and Specifications
12.1.4 Anhui Hyea Aromas Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Anhui Hyea Aromas Gamma Valerolactone Sales by Product in 2024
12.1.6 Anhui Hyea Aromas Gamma Valerolactone Sales by Application in 2024
12.1.7 Anhui Hyea Aromas Gamma Valerolactone Sales by Geographic Area in 2024
12.1.8 Anhui Hyea Aromas Gamma Valerolactone SWOT Analysis
12.1.9 Anhui Hyea Aromas Recent Developments
12.2 Dideu Industries
12.2.1 Dideu Industries Corporation Information
12.2.2 Dideu Industries Business Overview
12.2.3 Dideu Industries Gamma Valerolactone Product Models, Descriptions and Specifications
12.2.4 Dideu Industries Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Dideu Industries Gamma Valerolactone Sales by Product in 2024
12.2.6 Dideu Industries Gamma Valerolactone Sales by Application in 2024
12.2.7 Dideu Industries Gamma Valerolactone Sales by Geographic Area in 2024
12.2.8 Dideu Industries Gamma Valerolactone SWOT Analysis
12.2.9 Dideu Industries Recent Developments
12.3 Kunshan Qiandeng Baihua
12.3.1 Kunshan Qiandeng Baihua Corporation Information
12.3.2 Kunshan Qiandeng Baihua Business Overview
12.3.3 Kunshan Qiandeng Baihua Gamma Valerolactone Product Models, Descriptions and Specifications
12.3.4 Kunshan Qiandeng Baihua Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Kunshan Qiandeng Baihua Gamma Valerolactone Sales by Product in 2024
12.3.6 Kunshan Qiandeng Baihua Gamma Valerolactone Sales by Application in 2024
12.3.7 Kunshan Qiandeng Baihua Gamma Valerolactone Sales by Geographic Area in 2024
12.3.8 Kunshan Qiandeng Baihua Gamma Valerolactone SWOT Analysis
12.3.9 Kunshan Qiandeng Baihua Recent Developments
12.4 Zhongyue Aroma
12.4.1 Zhongyue Aroma Corporation Information
12.4.2 Zhongyue Aroma Business Overview
12.4.3 Zhongyue Aroma Gamma Valerolactone Product Models, Descriptions and Specifications
12.4.4 Zhongyue Aroma Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Zhongyue Aroma Gamma Valerolactone Sales by Product in 2024
12.4.6 Zhongyue Aroma Gamma Valerolactone Sales by Application in 2024
12.4.7 Zhongyue Aroma Gamma Valerolactone Sales by Geographic Area in 2024
12.4.8 Zhongyue Aroma Gamma Valerolactone SWOT Analysis
12.4.9 Zhongyue Aroma Recent Developments
12.5 Soda Aromatic
12.5.1 Soda Aromatic Corporation Information
12.5.2 Soda Aromatic Business Overview
12.5.3 Soda Aromatic Gamma Valerolactone Product Models, Descriptions and Specifications
12.5.4 Soda Aromatic Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Soda Aromatic Gamma Valerolactone Sales by Product in 2024
12.5.6 Soda Aromatic Gamma Valerolactone Sales by Application in 2024
12.5.7 Soda Aromatic Gamma Valerolactone Sales by Geographic Area in 2024
12.5.8 Soda Aromatic Gamma Valerolactone SWOT Analysis
12.5.9 Soda Aromatic Recent Developments
12.6 Inoue Perfumery MFG
12.6.1 Inoue Perfumery MFG Corporation Information
12.6.2 Inoue Perfumery MFG Business Overview
12.6.3 Inoue Perfumery MFG Gamma Valerolactone Product Models, Descriptions and Specifications
12.6.4 Inoue Perfumery MFG Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Inoue Perfumery MFG Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Gamma Valerolactone Industry Chain
13.2 Gamma Valerolactone Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Gamma Valerolactone Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Gamma Valerolactone Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Gamma Valerolactone Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Gamma Valerolactone Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Gamma Valerolactone Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gamma Valerolactone Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gamma Valerolactone Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gamma Valerolactone Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gamma Valerolactone Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Gamma Valerolactone Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 7. Global Gamma Valerolactone Sales by Region (2020-2025) & (Kg)
Table 8. Global Gamma Valerolactone Sales by Region (2026-2031) & (Kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Gamma Valerolactone Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 11. Global Gamma Valerolactone Production by Region (2020-2025) & (Kg)
Table 12. Global Gamma Valerolactone Production by Region (2026-2031) & (Kg)
Table 13. Global Gamma Valerolactone Sales by Manufacturers (2020-2025) & (Kg)
Table 14. Global Gamma Valerolactone Sales Share by Manufacturers (2020-2025)
Table 15. Global Gamma Valerolactone Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Gamma Valerolactone Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Gamma Valerolactone by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma Valerolactone as of 2024)
Table 19. Global Gamma Valerolactone Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Gamma Valerolactone Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
Table 21. Key Manufacturers Gamma Valerolactone Manufacturing Base and Headquarters
Table 22. Global Gamma Valerolactone Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Gamma Valerolactone Sales by Type (2020-2025) & (Kg)
Table 26. Global Gamma Valerolactone Sales by Type (2026-2031) & (Kg)
Table 27. Global Gamma Valerolactone Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Gamma Valerolactone Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Gamma Valerolactone ASP by Type (2020-2031) & (US$/Kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Gamma Valerolactone Sales by Application (2020-2025) & (Kg)
Table 32. Global Gamma Valerolactone Sales by Application (2026-2031) & (Kg)
Table 33. Gamma Valerolactone High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Gamma Valerolactone Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Gamma Valerolactone Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Gamma Valerolactone ASP by Application (2020-2031) & (US$/Kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Gamma Valerolactone Growth Accelerators and Market Barriers
Table 40. North America Gamma Valerolactone Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Gamma Valerolactone Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Gamma Valerolactone Growth Accelerators and Market Barriers
Table 43. Europe Gamma Valerolactone Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Gamma Valerolactone Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Gamma Valerolactone Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Gamma Valerolactone Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Gamma Valerolactone Growth Accelerators and Market Barriers
Table 48. Southeast Asia Gamma Valerolactone Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Gamma Valerolactone Investment Opportunities and Key Challenges
Table 50. Central and South America Gamma Valerolactone Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Gamma Valerolactone Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Gamma Valerolactone Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Anhui Hyea Aromas Corporation Information
Table 54. Anhui Hyea Aromas Description and Major Businesses
Table 55. Anhui Hyea Aromas Product Models, Descriptions and Specifications
Table 56. Anhui Hyea Aromas Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 57. Anhui Hyea Aromas Sales Value Proportion by Product in 2024
Table 58. Anhui Hyea Aromas Sales Value Proportion by Application in 2024
Table 59. Anhui Hyea Aromas Sales Value Proportion by Geographic Area in 2024
Table 60. Anhui Hyea Aromas Gamma Valerolactone SWOT Analysis
Table 61. Anhui Hyea Aromas Recent Developments
Table 62. Dideu Industries Corporation Information
Table 63. Dideu Industries Description and Major Businesses
Table 64. Dideu Industries Product Models, Descriptions and Specifications
Table 65. Dideu Industries Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 66. Dideu Industries Sales Value Proportion by Product in 2024
Table 67. Dideu Industries Sales Value Proportion by Application in 2024
Table 68. Dideu Industries Sales Value Proportion by Geographic Area in 2024
Table 69. Dideu Industries Gamma Valerolactone SWOT Analysis
Table 70. Dideu Industries Recent Developments
Table 71. Kunshan Qiandeng Baihua Corporation Information
Table 72. Kunshan Qiandeng Baihua Description and Major Businesses
Table 73. Kunshan Qiandeng Baihua Product Models, Descriptions and Specifications
Table 74. Kunshan Qiandeng Baihua Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Kunshan Qiandeng Baihua Sales Value Proportion by Product in 2024
Table 76. Kunshan Qiandeng Baihua Sales Value Proportion by Application in 2024
Table 77. Kunshan Qiandeng Baihua Sales Value Proportion by Geographic Area in 2024
Table 78. Kunshan Qiandeng Baihua Gamma Valerolactone SWOT Analysis
Table 79. Kunshan Qiandeng Baihua Recent Developments
Table 80. Zhongyue Aroma Corporation Information
Table 81. Zhongyue Aroma Description and Major Businesses
Table 82. Zhongyue Aroma Product Models, Descriptions and Specifications
Table 83. Zhongyue Aroma Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 84. Zhongyue Aroma Sales Value Proportion by Product in 2024
Table 85. Zhongyue Aroma Sales Value Proportion by Application in 2024
Table 86. Zhongyue Aroma Sales Value Proportion by Geographic Area in 2024
Table 87. Zhongyue Aroma Gamma Valerolactone SWOT Analysis
Table 88. Zhongyue Aroma Recent Developments
Table 89. Soda Aromatic Corporation Information
Table 90. Soda Aromatic Description and Major Businesses
Table 91. Soda Aromatic Product Models, Descriptions and Specifications
Table 92. Soda Aromatic Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Soda Aromatic Sales Value Proportion by Product in 2024
Table 94. Soda Aromatic Sales Value Proportion by Application in 2024
Table 95. Soda Aromatic Sales Value Proportion by Geographic Area in 2024
Table 96. Soda Aromatic Gamma Valerolactone SWOT Analysis
Table 97. Soda Aromatic Recent Developments
Table 98. Inoue Perfumery MFG Corporation Information
Table 99. Inoue Perfumery MFG Description and Major Businesses
Table 100. Inoue Perfumery MFG Product Models, Descriptions and Specifications
Table 101. Inoue Perfumery MFG Capacity, Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 102. Inoue Perfumery MFG Recent Developments
Table 103. Key Raw Materials Distribution
Table 104. Raw Materials Key Suppliers
Table 105. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 106. Milestones in Production Technology Evolution
Table 107. Distributors List
Table 108. Market Trends and Market Evolution
Table 109. Market Drivers and Opportunities
Table 110. Market Challenges, Risks, and Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Gamma Valerolactone Product Picture
Figure 2. Global Gamma Valerolactone Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Food Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Global Gamma Valerolactone Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Food Flavors
Figure 7. Solvent
Figure 8. Monomer Intermediate
Figure 9. Others
Figure 10. Gamma Valerolactone Report Years Considered
Figure 11. Global Gamma Valerolactone Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 13. Global Gamma Valerolactone Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Gamma Valerolactone Revenue Market Share by Region (2020-2031)
Figure 15. Global Gamma Valerolactone Sales (2020-2031) & (Kg)
Figure 16. Global Gamma Valerolactone Sales (CAGR) by Region (2020-2031) (Kg)
Figure 17. Global Gamma Valerolactone Sales Market Share by Region (2020-2031)
Figure 18. Global Gamma Valerolactone Capacity, Production and Utilization (2020-2031) & (Kg)
Figure 19. Global Gamma Valerolactone Production Trend by Region (2020-2031) (Kg)
Figure 20. Global Gamma Valerolactone Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Gamma Valerolactone Production Growth Rate in North America (2020-2031) & (Kg)
Figure 23. Gamma Valerolactone Production Growth Rate in Europe (2020-2031) & (Kg)
Figure 24. Gamma Valerolactone Production Growth Rate in China (2020-2031) & (Kg)
Figure 25. Gamma Valerolactone Production Growth Rate in Japan (2020-2031) & (Kg)
Figure 26. Top 5 and Top 10 Manufacturers Gamma Valerolactone Sales Volume Market Share in 2024
Figure 27. Global Gamma Valerolactone Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Food Grade Revenue Market Share by Manufacturer in 2024
Figure 30. Industrial Grade Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Gamma Valerolactone Sales Market Share by Type (2020-2031)
Figure 34. Global Gamma Valerolactone Revenue Market Share by Type (2020-2031)
Figure 35. Global Gamma Valerolactone Sales Market Share by Application (2020-2031)
Figure 36. Global Gamma Valerolactone Revenue Market Share by Application (2020-2031)
Figure 37. North America Gamma Valerolactone Sales YoY (2020-2031) & (Kg)
Figure 38. North America Gamma Valerolactone Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2024
Figure 40. North America Gamma Valerolactone Sales Volume (Kg) by Type (2020- 2031)
Figure 41. North America Gamma Valerolactone Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Gamma Valerolactone Sales Volume (Kg) by Application (2020-2031)
Figure 43. North America Gamma Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Gamma Valerolactone Sales YoY (2020-2031) & (Kg)
Figure 48. Europe Gamma Valerolactone Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2024
Figure 50. Europe Gamma Valerolactone Sales Volume (Kg) by Type (2020-2031)
Figure 51. Europe Gamma Valerolactone Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Gamma Valerolactone Sales Volume (Kg) by Application (2020-2031)
Figure 53. Europe Gamma Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 55. France Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Gamma Valerolactone Sales YoY (2020-2031) & (Kg)
Figure 60. Asia-Pacific Gamma Valerolactone Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Gamma Valerolactone Sales Volume (Kg) by Type (2020- 2031)
Figure 63. Asia-Pacific Gamma Valerolactone Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Gamma Valerolactone Sales Volume (Kg) by Application (2020-2031)
Figure 65. Asia-Pacific Gamma Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 70. India Gamma Valerolactone Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Gamma Valerolactone Sales YoY (2020-2031) & (Kg)
Figure 72. Central and South America Gamma Valerolactone Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Gamma Valerolactone Sales Volume (Kg) by Type (2021-2031)
Figure 75. Central and South America Gamma Valerolactone Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Gamma Valerolactone Sales Volume (Kg) by Application (2020-2031)
Figure 77. Central and South America Gamma Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Gamma Valerolactone Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Gamma Valerolactone Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Gamma Valerolactone Sales YoY (2020-2031) & (Kg)
Figure 81. Middle East and Africa Gamma Valerolactone Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Gamma Valerolactone Sales Volume (Kg) by Type (2021-2031)
Figure 84. South America Gamma Valerolactone Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Gamma Valerolactone Sales Volume (Kg) by Application (2020-2031)
Figure 86. Middle East and Africa Gamma Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Gamma Valerolactone Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Gamma Valerolactone Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Gamma Valerolactone Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Gamma Valerolactone Revenue (2020-2025) & (US$ Million)
Figure 91. Gamma Valerolactone Industry Chain Mapping
Figure 92. Regional Gamma Valerolactone Manufacturing Base Distribution (%)
Figure 93. Gamma Valerolactone Production Process
Figure 94. Regional Gamma Valerolactone Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Gamma Valerolactone in 2025?
The global market size of Gamma Valerolactone in 2025 was 602 Million USD.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Gamma Valerolactone market size from 2025 to 2031?
Which companies rank high in the global Gamma Valerolactone market?
What was the global market size of Gamma Valerolactone in 2031?
Related Reports
Global Gamma Valerolactone Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
Global Gamma Valerolactone Market Research Report 2025
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published Date: 2025-09-12
Pages: 94
USD 2900.00
(Single User License)
Gamma Valerolactone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Gamma Valerolactone Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
Global Gamma Valerolactone Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-09-12
Pages: 78
USD 4250.00
(Single User License)
Gamma Valerolactone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-10-15
Pages: 109
USD 3950.00
(Single User License)
Gamma Valerolactone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 135
USD 3950.00
(Single User License)
Global Gamma Valerolactone Market Research Report 2026
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 133
USD 2900.00
(Single User License)
Global Gamma Valerolactone Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published Date: 2026-08-07
Pages: 128
USD 4250.00
(Single User License)
Global Gamma Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-07
Pages: 141
USD 4900.00
(Single User License)
Global Gamma Valerolactone Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published: 2024-04-17
Pages: 151
USD 5600.00 (Single User License)Global Gamma Valerolactone Market Research Report 2025
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published: 2025-09-12
Pages: 94
USD 2900.00 (Single User License)Gamma Valerolactone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)Global Gamma Valerolactone Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
USD 5900.00 (Single User License)Global Gamma Valerolactone Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-09-12
Pages: 78
USD 4250.00 (Single User License)Gamma Valerolactone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-10-15
Pages: 109
USD 3950.00 (Single User License)Gamma Valerolactone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 135
USD 3950.00 (Single User License)Global Gamma Valerolactone Market Research Report 2026
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 133
USD 2900.00 (Single User License)Global Gamma Valerolactone Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published: 2026-08-07
Pages: 128
USD 4250.00 (Single User License)Global Gamma Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-07
Pages: 141
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
Why This Report?
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report